Registered entities
Aboleris Holdco
Reg. No. 0803.217.012Belgium
Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace accelerating. Cited 87 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 2.1K social following, 9 posts in the last 12 months — top 10% of its industry.
Investor mix
9 investors on record; lead investors include Caixa Capital Risc.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 44% |
| Private equity | 3 | 33% |
| Other / undisclosed | 2 | 22% |
Recent activity
29 Apr 2026
Event
Day of Immunology webinar on regulatory T cells (#Tregs)
12 Jan 2026
Milestone
regulatory
18 Dec 2025
Event
Biotech Showcase 2026